Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × Disulfides × 90 days × Clear all

Sponsor

Conditions

Lung Neoplasms 14 Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 5 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Urogenital Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Melanoma 2 Lymphoid Interstitial Pneumonia 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colitis 2 Brenner Tumor 2 Brain Neoplasms 2 Adenocarcinoma, Mucinous 2 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1

Interventions

venetoclax 42 Rituximab 25 obinutuzumab 22 ibrutinib 22 Cyclophosphamide 22 acalabrutinib 19 pirtobrutinib 17 fludarabine 17 Specimen Handling 11 zanubrutinib 10 fludarabine phosphate 10 Biopsy 10 Bendamustine Hydrochloride 10 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 5 Prednisone 5 Lenalidomide 5 idelalisib 4 Vincristine 4 Mycophenolic Acid 4 Doxorubicin 4 CT-P10 4 ARQ531 4 pembrolizumab 3 Tacrolimus 3 tocilizumab 2 duvelisib 2 daratumumab 2 atezolizumab 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡